Anthem Biosciences released its voluntary FY26 BRSR, highlighting significant R&D (14%) and Capex (51%) for sustainability and technology.

The CRDMO business exports 85% of revenue.

The company achieved zero safety incidents and improved GHG intensity.

Supply chain sourcing from India notably increased to 85%.